496 Results
Guidelines and Advice
Status: Current
Apr 2017
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Symptom Management
Symptom Management
Symptom Management
Drug
Dec 2024
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Sep 2025
Drug
Apr 2023
